TY - JOUR AU - Ajay, S. AU - Rohit, S. PY - 2012 DA - 2012// TI - Validation of analytical procedures: a comparison of ICH vs. pharmacopoeia (USP) vs FDA JO - Int Res J Pharm VL - 3 ID - Ajay2012 ER - TY - JOUR AU - Amin, K. C. AU - Patel, S. AU - Oke, A. AU - Saha, G. B. PY - 2011 DA - 2011// TI - An alternative method for determining the radiochemical purity of 99mTc-Tetrofosmin JO - J Nucl Med Technol VL - 39 UR - https://doi.org/10.2967/jnmt.110.080788 DO - 10.2967/jnmt.110.080788 ID - Amin2011 ER - TY - STD TI - Boersma HH, Stolk LM, Kenis H, Deckers NM, Vanderheyden JL, Hofstra L, Heidendal GA. Reutelingsperger CP. The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5. Anal Biochem. 2004;327(1):126–34. ID - ref3 ER - TY - JOUR AU - Chen, F. AU - Decristoforo, C. AU - Rohrbacher, B. AU - Riccabona, G. PY - 1993 DA - 1993// TI - A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyl triglycine JO - Eur J Nucl Med VL - 20 UR - https://doi.org/10.1007/BF00169810 DO - 10.1007/BF00169810 ID - Chen1993 ER - TY - BOOK AU - Decristoforo, C. AU - Zolle, I. PY - 2007 DA - 2007// TI - Technetium-99m pharmaceuticals; preparation and quality control in nuclear medicine PB - Springer CY - Berlin Heidelberg New York UR - https://doi.org/10.1007/978-3-540-33990-8_9 DO - 10.1007/978-3-540-33990-8_9 ID - Decristoforo2007 ER - TY - JOUR AU - Dondi, M. AU - Kashyap, R. AU - Paez, D. AU - Pascual, T. AU - Zaknun, J. AU - Mut, F. PY - 2011 DA - 2011// TI - Trends in nuclear medicine in developing countries JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.111.089193 DO - 10.2967/jnumed.111.089193 ID - Dondi2011 ER - TY - JOUR AU - Elsinga, P. AU - Todde, S. AU - Penuelas, I. AU - Meyer, G. AU - Farstad, B. AU - Faivre-Chauvet, A. PY - 2010 DA - 2010// TI - Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-010-1407-3 DO - 10.1007/s00259-010-1407-3 ID - Elsinga2010 ER - TY - BOOK PY - 2018 DA - 2018// TI - Guide for the elaboration of monographs on Radiopharmaceutical Preparations ID - ref8 ER - TY - JOUR AU - Faria, D. P. AU - Buchpiguel, C. A. AU - Marques, F. L. N. PY - 2015 DA - 2015// TI - Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [99mTc(MIBI)6]+ JO - Braz J Med Biol Res VL - 48 UR - https://doi.org/10.1590/1414-431x20144489 DO - 10.1590/1414-431x20144489 ID - Faria2015 ER - TY - JOUR AU - Hammes, R. AU - Joas, L. A. AU - Kirschling, T. E. AU - Ledford, J. R. AU - Knox, T. L. AU - Nybo, M. R. PY - 2004 DA - 2004// TI - A better method of quality control for 99mTc- Tetrosfosmin JO - J Nucl Med Technol VL - 32 ID - Hammes2004 ER - TY - BOOK PY - 2016 DA - 2016// TI - Good practice for introducing radiopharmaceuticals for clinical use. International Atomic Energy Agency ID - ref11 ER - TY - BOOK PY - 2006 DA - 2006// TI - ICH topic Q 2 (R1) validation of analytical procedures: text and methodology. EMEA ID - ref12 ER - TY - BOOK PY - 2008 DA - 2008// TI - Operational guidance on hospital radiopharmacy, a safe and effective approach. IAEA ID - ref13 ER - TY - STD TI - Krause S. Good analytical method validation practice, part I: setting-up for compliance and efficiency. J Val Tech. 2002;9:23–32. ID - ref14 ER - TY - STD TI - Krause S. Good analytical method validation practice. Deriving acceptance criteria for the AMV protocol: part II. J Val Tech. 2003;9:162–78. ID - ref15 ER - TY - JOUR AU - Leonardi, N. AU - Casale, G. AU - Nicolini, J. AU - Zubata, P. AU - Salgueiro, M. AU - Zubillaga, M. PY - 2012 DA - 2012// TI - Validation of a paper chromatographic methodology as an alternative for determination of the radiochemical purity of Na18F JO - J Nucl Med Technol VL - 40 UR - https://doi.org/10.2967/jnmt.112.107664 DO - 10.2967/jnmt.112.107664 ID - Leonardi2012 ER - TY - STD TI - Loveless V. Quality control of compounded radiopharmaceuticals, continuing education for nuclear pharmacist and nuclear medicine professionals: University of New Mexico Health Sciences Center College of Pharmacy, Albuquerque; 2009;15(XV), Lesson 3:9–12. ID - ref17 ER - TY - JOUR AU - Luebke, A. L. AU - Wilary, D. M. AU - Mahoney, D. W. AU - Hung, J. C. PY - 2000 DA - 2000// TI - Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi JO - J Nucl Med Technol VL - 28 ID - Luebke2000 ER - TY - CHAP AU - Mambilima, N. PY - 2016 DA - 2016// TI - Validation of radiochemical purity analysis methods used in two tertiary public hospitals in South Africa BT - Thesis submitted in partial fulfilment of the requirements for the degree of Master of Science in Nuclear Medicine in the Faculty of Medicine and Health Sciences at Stellenbosch University ID - Mambilima2016 ER - TY - BOOK AU - Mihon, M. AU - Tuta, C. AU - Manea, C. AU - Ion, A. AU - Lavric, V. PY - 2016 DA - 2016// TI - Validation of the HPLC method for determination of identity and radiochemical purity of [18F]Na U.P.B. Scientific Bulletin ID - Mihon2016 ER - TY - STD TI - Millar AM, Beattie LA, Craig F, O’Brien LM. An evaluation of GMCP-SA as a replacement for ITLC-SG when measuring the levels of radiochemical impurities in 99mTc-radiopharmaceuticals by thin-layer chromatography. J Label Compd Radiopharm. 2009;52:538–42. ID - ref21 ER - TY - STD TI - Osteocis 3mg. Kit for radiopharmaceutical preparation. Summary of product characteristics. IBA molecular; 2016. ID - ref22 ER - TY - STD TI - Renocis. Kit for preparation of technetium [99mTc] - succimer injection. Summary of product characteristics, CIS bio international; 2016. ID - ref23 ER - TY - BOOK AU - Saha, G. B. PY - 2010 DA - 2010// TI - Fundamentals of nuclear pharmacy PB - Springer CY - New York UR - https://doi.org/10.1007/978-1-4419-5860-0 DO - 10.1007/978-1-4419-5860-0 ID - Saha2010 ER - TY - JOUR AU - Seetharaman, S. AU - Ballinger, J. AU - Sosabowski, M. H. PY - 2006 DA - 2006// TI - Simplified method for determining the radiochemical purity of 99mTc-MAG3 JO - J Nucl Med Technol VL - 34 ID - Seetharaman2006 ER - TY - STD TI - Stamicis, Kit for radiopharmaceutical preparation. Summary of product characteristics, IBA molecular; 2016. ID - ref26 ER - TY - STD TI - Todde S, Kolenc Peitl P, Elsinga P, Koziorowski J, Ferrari V, Ocak E, et al. Guidance on validation and quantification of processes and operations involving radiopharmaceuticals. Eur J Nucl Med Mol Imaging Radiopharm Chem. 2017;2:8. ID - ref27 ER - TY - JOUR AU - Todde, S. AU - Windhorst, A. D. AU - Behe, M. AU - Bormans, G. AU - Decristoforo, C. AU - Faivre-Chauvet, A. PY - 2014 DA - 2014// TI - EANM guideline for preparation of an investigational medicinal product dossier (IMPD) JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-014-2866-8 DO - 10.1007/s00259-014-2866-8 ID - Todde2014 ER - TY - BOOK PY - 2008 DA - 2008// TI - Validation of compendial procedures ID - ref29 ER - TY - STD TI - Vincenti LP, Samuel A, Zarb F. Establishing radiopharmaceutical standards at a nuclear medicine unit in Malta. Int J Radiol Imaging Technol. 2016;2:012. ID - ref30 ER -